Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 97

1.

Extracellular fluid volume is associated with incident end-stage kidney disease and mortality in patients with chronic kidney disease.

Faucon AL, Flamant M, Metzger M, Boffa JJ, Haymann JP, Houillier P, Thervet E, Vrtovsnik F, Stengel B, Geri G, Vidal-Petiot E; NephroTest Study Group.

Kidney Int. 2019 Oct;96(4):1020-1029. doi: 10.1016/j.kint.2019.06.017. Epub 2019 Jul 16.

PMID:
31477263
2.

MYH9-related disorders display heterogeneous kidney involvement and outcome.

Tabibzadeh N, Fleury D, Labatut D, Bridoux F, Lionet A, Jourde-Chiche N, Vrtovsnik F, Schlegel N, Vanhille P.

Clin Kidney J. 2018 Dec 17;12(4):494-502. doi: 10.1093/ckj/sfy117. eCollection 2019 Aug.

3.

Disseminated toxoplasmosis associated with hemophagocytic syndrome after kidney transplantation: A case report and review.

Gay J, Gendron N, Verney C, Joste V, Dardé ML, Loheac C, Vrtovsnik F, Argy N, Houze S.

Transpl Infect Dis. 2019 Aug 2:e13154. doi: 10.1111/tid.13154. [Epub ahead of print]

PMID:
31373746
4.

Evolution Over Time of Volume Status and PD-Related Practice Patterns in an Incident Peritoneal Dialysis Cohort.

Van Biesen W, Verger C, Heaf J, Vrtovsnik F, Britto ZML, Do JY, Prieto-Velasco M, Martínez JP, Crepaldi C, De Los Ríos T, Gauly A, Ihle K, Ronco C; IPOD-PD Study Group.

Clin J Am Soc Nephrol. 2019 Jun 7;14(6):882-893. doi: 10.2215/CJN.11590918. Epub 2019 May 23.

PMID:
31123180
5.

Risk of Perforated Colonic Diverticulitis in Patients With Chronic Kidney Disease Requiring Sodium Polystyrene Sulfonate: Not to Be Forgotten.

Nassereddine H, Pelletier AL, Chemouny JM, Rebibo L, Vrtovsnik F, Msika S, Couvelard A, Sannier A.

Am J Gastroenterol. 2019 Jun;114(6):1003-1005. doi: 10.14309/ajg.0000000000000276. No abstract available.

PMID:
31107688
6.

[Chronic metabolic and renal disorders related to lithium salts treatment].

Tabibzadeh N, Vrtovsnik F, Serrano F, Vidal-Petiot E, Flamant M.

Rev Med Interne. 2019 Sep;40(9):599-608. doi: 10.1016/j.revmed.2019.01.006. Epub 2019 Mar 1. French.

PMID:
30827493
7.

Fasting Urinary Osmolality, CKD Progression, and Mortality: A Prospective Observational Study.

Tabibzadeh N, Wagner S, Metzger M, Flamant M, Houillier P, Boffa JJ, Vrtovsnik F, Thervet E, Stengel B, Haymann JP; NephroTest Study Group.

Am J Kidney Dis. 2019 May;73(5):596-604. doi: 10.1053/j.ajkd.2018.12.024. Epub 2019 Feb 15. Erratum in: Am J Kidney Dis. 2019 Sep 18;:.

PMID:
30777634
8.

Severe Chronic Kidney Disease Is Associated with a Lower Efficiency of Bariatric Surgery.

Hansel B, Arapis K, Kadouch D, Ledoux S, Coupaye M, Msika S, Vrtovsnik F, Marre M, Boutten A, Cherifi B, Cambos S, Beslay M, Courie R, Roussel R.

Obes Surg. 2019 May;29(5):1514-1520. doi: 10.1007/s11695-019-03703-z.

PMID:
30685835
9.

Risk of Ascending Aortic Aneurysm in Patients With Autosomal Dominant Polycystic Kidney Disease.

Bouleti C, Flamant M, Escoubet B, Arnoult F, Milleron O, Vidal-Petiot E, Langeois M, Ou P, Vrtovsnik F, Jondeau G.

Am J Cardiol. 2019 Feb 1;123(3):482-488. doi: 10.1016/j.amjcard.2018.10.030. Epub 2018 Nov 6.

PMID:
30477801
10.

Modulation of the microbiota by oral antibiotics treats immunoglobulin A nephropathy in humanized mice.

Chemouny JM, Gleeson PJ, Abbad L, Lauriero G, Boedec E, Le Roux K, Monot C, Bredel M, Bex-Coudrat J, Sannier A, Daugas E, Vrtovsnik F, Gesualdo L, Leclerc M, Berthelot L, Ben Mkaddem S, Lepage P, Monteiro RC.

Nephrol Dial Transplant. 2019 Jul 1;34(7):1135-1144. doi: 10.1093/ndt/gfy323.

PMID:
30462346
11.

Extracellular Fluid Volume Is an Independent Determinant of Uncontrolled and Resistant Hypertension in Chronic Kidney Disease: A NephroTest Cohort Study.

Vidal-Petiot E, Metzger M, Faucon AL, Boffa JJ, Haymann JP, Thervet E, Houillier P, Geri G, Stengel B, Vrtovsnik F, Flamant M; NephroTest study group.

J Am Heart Assoc. 2018 Oct 2;7(19):e010278. doi: 10.1161/JAHA.118.010278.

12.

Malakoplakia as a cause of severe hypercalcemia through ectopic 25-hydroxyvitamin D3 1-alpha-hydroxylase expression: A case report.

Chemouny JM, Sannier A, Hanouna G, Champion L, Vrtovsnik F, Daugas E.

Medicine (Baltimore). 2018 Oct;97(40):e12090. doi: 10.1097/MD.0000000000012090.

13.

IgA kappa light and heavy chain deposition disease in multiple myeloma.

Sannier A, Hanouna G, Daugas E, Vrtovsnik F, Goujon JM, Chemouny JM.

Br J Haematol. 2018 Oct;183(1):13. doi: 10.1111/bjh.15420. Epub 2018 May 29. No abstract available.

PMID:
29808912
14.

Association of a Low-Protein Diet With Slower Progression of CKD.

Metzger M, Yuan WL, Haymann JP, Flamant M, Houillier P, Thervet E, Boffa JJ, Vrtovsnik F, Froissart M, Bankir L, Fouque D, Stengel B.

Kidney Int Rep. 2017 Aug 30;3(1):105-114. doi: 10.1016/j.ekir.2017.08.010. eCollection 2018 Jan.

15.

Value of biomarkers for predicting immunoglobulin A vasculitis nephritis outcome in an adult prospective cohort.

Berthelot L, Jamin A, Viglietti D, Chemouny JM, Ayari H, Pierre M, Housset P, Sauvaget V, Hurtado-Nedelec M, Vrtovsnik F, Daugas E; HSPrognosis Group, Monteiro RC, Pillebout E; members of the HSPrognosis Group.

Nephrol Dial Transplant. 2018 Sep 1;33(9):1579-1590. doi: 10.1093/ndt/gfx300.

PMID:
29126311
16.

External validation and comparison of formulae estimating 24-h sodium intake from a fasting morning urine sample.

Vidal-Petiot E, Joseph A, Resche-Rigon M, Boutten A, Mullaert J, d' Ortho MP, Vrtovsnik F, Steg PG, Flamant M.

J Hypertens. 2018 Apr;36(4):785-792. doi: 10.1097/HJH.0000000000001609.

PMID:
29120960
17.

Correction to: Association of plasma potassium with mortality and end-stage kidney disease in patients with chronic kidney disease under nephrologist care - The NephroTest study.

Wagner S, Metzger M, Flamant M, Houillier P, Haymann JP, Vrtovsnik F, Thervet E, Boffa JJ, Massy ZA, Stengel B, Rossignol P; NephroTest Study group.

BMC Nephrol. 2017 Oct 6;18(1):308. doi: 10.1186/s12882-017-0723-2. No abstract available.

18.

Association of plasma potassium with mortality and end-stage kidney disease in patients with chronic kidney disease under nephrologist care - The NephroTest study.

Wagner S, Metzger M, Flamant M, Houillier P, Haymann JP, Vrtovsnik F, Thervet E, Boffa JJ, Massy ZA, Stengel B, Rossignol P; NephroTest Study group.

BMC Nephrol. 2017 Sep 12;18(1):295. doi: 10.1186/s12882-017-0710-7. Erratum in: BMC Nephrol. 2017 Oct 6;18(1):308.

19.

Serum Iron Protects from Renal Postischemic Injury.

Vaugier C, Amano MT, Chemouny JM, Dussiot M, Berrou C, Matignon M, Ben Mkaddem S, Wang PHM, Fricot A, Maciel TT, Grapton D, Mathieu JRR, Beaumont C, Peraldi MN, Peyssonnaux C, Mesnard L, Daugas E, Vrtovsnik F, Monteiro RC, Hermine O, Ginzburg YZ, Benhamou M, Camara NOS, Flamant M, Moura IC.

J Am Soc Nephrol. 2017 Dec;28(12):3605-3615. doi: 10.1681/ASN.2016080926. Epub 2017 Aug 7.

20.

Les enjeux de la surcharge hydro-sodée.

Vrtovsnik F, Fartoux L.

Nephrol Ther. 2016 Dec;12(7S):S10-S11. doi: 10.1016/S1769-7255(17)30020-2. French. No abstract available.

PMID:
28132669
21.

Renal biopsies should be performed whenever treatment strategies depend on renal involvement.

Divard G, Sannier A, Hanouna G, Daugas E, Vrtovsnik F, Chemouny JM.

Ann Rheum Dis. 2017 Aug;76(8):e27. doi: 10.1136/annrheumdis-2016-210933. Epub 2017 Jan 25. No abstract available.

PMID:
28122762
22.

Estimated or Measured GFR in Living Kidney Donors Work-up?

Gaillard F, Flamant M, Lemoine S, Baron S, Timsit MO, Eladari D, Fournier C, Prot-Bertoye C, Bertocchio JP, Vidal-Petiot E, Lamhaut L, Morelon E, Péraldi MN, Vrtovsnik F, Friedlander G, Méjean A, Houillier P, Legendre C, Courbebaisse M.

Am J Transplant. 2016 Oct;16(10):3024-3032. doi: 10.1111/ajt.13908. Epub 2016 Jul 15.

23.

Low Serum Creatine Kinase Level Predicts Mortality in Patients with a Chronic Kidney Disease.

Flahault A, Metzger M, Chassé JF, Haymann JP, Boffa JJ, Flamant M, Vrtovsnik F, Houillier P, Stengel B, Thervet E, Pallet N; NephroTest study group.

PLoS One. 2016 Jun 1;11(6):e0156433. doi: 10.1371/journal.pone.0156433. eCollection 2016.

24.

[A young man with proteinuria and hematuria on routine screening]

Vrtovsnik F.

Rev Prat. 2016 Mar;66(3):285-289. French. No abstract available.

PMID:
30512638
25.

Creatinine-based equations for the adjustment of drug dosage in an obese population.

Bouquegneau A, Vidal-Petiot E, Moranne O, Mariat C, Boffa JJ, Vrtovsnik F, Scheen AJ, Krzesinski JM, Flamant M, Delanaye P.

Br J Clin Pharmacol. 2016 Feb;81(2):349-61. doi: 10.1111/bcp.12817. Epub 2016 Jan 17.

26.

Protective role of mouse IgG1 in cryoglobulinaemia; insights from an animal model and relevance to human pathology.

Chemouny JM, Hurtado-Nedelec M, Flament H, Ben Mkaddem S, Daugas E, Vrtovsnik F, Berthelot L, Monteiro RC.

Nephrol Dial Transplant. 2016 Aug;31(8):1235-42. doi: 10.1093/ndt/gfv335. Epub 2015 Sep 26. Review.

PMID:
26410885
27.

Glycated Hemoglobin Level and Mortality in a Nondiabetic Population with CKD.

Trivin C, Metzger M, Haymann JP, Boffa JJ, Flamant M, Vrtovsnik F, Houillier P, Stengel B, Thervet E; NephroTest Study Group.

Clin J Am Soc Nephrol. 2015 Jun 5;10(6):957-64. doi: 10.2215/CJN.08540814. Epub 2015 May 15.

28.

Urinary creatinine excretion, measured glomerular filtration rate and CKD outcomes.

Tynkevich E, Flamant M, Haymann JP, Metzger M, Thervet E, Boffa JJ, Vrtovsnik F, Houillier P, Froissart M, Stengel B; NephroTest Study Group.

Nephrol Dial Transplant. 2015 Aug;30(8):1386-94. doi: 10.1093/ndt/gfv047. Epub 2015 Mar 27.

PMID:
25817225
29.

Gluten exacerbates IgA nephropathy in humanized mice through gliadin-CD89 interaction.

Papista C, Lechner S, Ben Mkaddem S, LeStang MB, Abbad L, Bex-Coudrat J, Pillebout E, Chemouny JM, Jablonski M, Flamant M, Daugas E, Vrtovsnik F, Yiangou M, Berthelot L, Monteiro RC.

Kidney Int. 2015 Aug;88(2):276-85. doi: 10.1038/ki.2015.94. Epub 2015 Mar 25.

30.

Urinary ammonia and long-term outcomes in chronic kidney disease.

Vallet M, Metzger M, Haymann JP, Flamant M, Gauci C, Thervet E, Boffa JJ, Vrtovsnik F, Froissart M, Stengel B, Houillier P; NephroTest Cohort Study group.

Kidney Int. 2015 Jul;88(1):137-45. doi: 10.1038/ki.2015.52. Epub 2015 Mar 11.

31.

Decrease in urinary creatinine excretion in early stage chronic kidney disease.

Tynkevich E, Flamant M, Haymann JP, Metzger M, Thervet E, Boffa JJ, Vrtovsnik F, Houillier P, Froissart M, Stengel B; NephroTest Study Group.

PLoS One. 2014 Nov 17;9(11):e111949. doi: 10.1371/journal.pone.0111949. eCollection 2014.

32.

In reply to 'external validation of the berlin initiative study equations'.

Vidal-Petiot E, Vrtovsnik F, Flamant M.

Am J Kidney Dis. 2014 Oct;64(4):659. doi: 10.1053/j.ajkd.2014.07.008. No abstract available.

PMID:
25257329
33.

The relation of hepcidin to iron disorders, inflammation and hemoglobin in chronic kidney disease.

Mercadal L, Metzger M, Haymann JP, Thervet E, Boffa JJ, Flamant M, Vrtovsnik F, Houillier P, Froissart M, Stengel B; NephroTest Study Group.

PLoS One. 2014 Jun 30;9(6):e99781. doi: 10.1371/journal.pone.0099781. eCollection 2014. Erratum in: PLoS One. 2015;10(3):e0123145. Mercadel, Lucile [corrected to Mercadal, Lucile].

34.

A 3-marker index improves the identification of iron disorders in CKD anaemia.

Mercadal L, Metzger M, Haymann JP, Thervet E, Boffa JJ, Flamant M, Vrtovsnik F, Gauci C, Froissart M, Stengel B; NephroTest Study Group.

PLoS One. 2014 Feb 19;9(2):e84144. doi: 10.1371/journal.pone.0084144. eCollection 2014. Erratum in: PLoS One. 2014;9(6):e100606.

35.

External validation of the BIS (Berlin Initiative Study)-1 GFR estimating equation in the elderly.

Vidal-Petiot E, Haymann JP, Letavernier E, Serrano F, Clerici C, Boffa JJ, Vrtovsnik F, Flamant M.

Am J Kidney Dis. 2014 May;63(5):865-7. doi: 10.1053/j.ajkd.2014.01.421. Epub 2014 Feb 20. No abstract available.

PMID:
24560028
36.

Brief report: prevalence of antineutrophil cytoplasmic antibodies in infective endocarditis.

Mahr A, Batteux F, Tubiana S, Goulvestre C, Wolff M, Papo T, Vrtovsnik F, Klein I, Iung B, Duval X; IMAGE Study Group.

Arthritis Rheumatol. 2014 Jun;66(6):1672-7. doi: 10.1002/art.38389.

37.

Renal function can improve at any stage of chronic kidney disease.

Weis L, Metzger M, Haymann JP, Thervet E, Flamant M, Vrtovsnik F, Gauci C, Houillier P, Froissart M, Letavernier E, Stengel B, Boffa JJ; NephroTest Study Group.

PLoS One. 2013 Dec 13;8(12):e81835. doi: 10.1371/journal.pone.0081835. eCollection 2013.

38.

Modification of Diet in Renal Disease versus Chronic Kidney Disease Epidemiology Collaboration equation to estimate glomerular filtration rate in obese patients.

Bouquegneau A, Vidal-Petiot E, Vrtovsnik F, Cavalier E, Rorive M, Krzesinski JM, Delanaye P, Flamant M.

Nephrol Dial Transplant. 2013 Nov;28 Suppl 4:iv122-30. doi: 10.1093/ndt/gft329. Epub 2013 Sep 11.

PMID:
24026245
39.

Relation between circulating levels of 25(OH) vitamin D and parathyroid hormone in chronic kidney disease: quest for a threshold.

Metzger M, Houillier P, Gauci C, Haymann JP, Flamant M, Thervet E, Boffa JJ, Vrtovsnik F, Froissart M, Stengel B, Ureña-Torres P; NephroTest Study Group.

J Clin Endocrinol Metab. 2013 Jul;98(7):2922-8. doi: 10.1210/jc.2013-1294. Epub 2013 Apr 30.

PMID:
23633202
40.

Clinicopathological study of glomerular diseases associated with sarcoidosis: a multicenter study.

Stehlé T, Joly D, Vanhille P, Boffa JJ, Rémy P, Mesnard L, Hoffmann M, Grimbert P, Choukroun G, Vrtovsnik F, Verine J, Desvaux D, Walker F, Lang P, Mahevas M, Sahali D, Audard V.

Orphanet J Rare Dis. 2013 Apr 30;8:65. doi: 10.1186/1750-1172-8-65.

41.

Performance of GFR estimating equations in African Europeans: basis for a lower race-ethnicity factor than in African Americans.

Flamant M, Vidal-Petiot E, Metzger M, Haymann JP, Letavernier E, Delatour V, Karras A, Thervet E, Boffa JJ, Houillier P, Stengel B, Vrtovsnik F, Froissart M; NephroTest Study Group.

Am J Kidney Dis. 2013 Jul;62(1):182-4. doi: 10.1053/j.ajkd.2013.03.015. Epub 2013 Apr 20. No abstract available.

PMID:
23608543
42.

MDRD versus CKD-EPI equation to estimate glomerular filtration rate in kidney transplant recipients.

Masson I, Flamant M, Maillard N, Rule AD, Vrtovsnik F, Peraldi MN, Thibaudin L, Cavalier E, Vidal-Petiot E, Bonneau C, Moranne O, Alamartine E, Mariat C, Delanaye P.

Transplantation. 2013 May 27;95(10):1211-7. doi: 10.1097/TP.0b013e318288caa6.

PMID:
23511243
43.

Impact of prior CKD management in a renal care network on early outcomes in incident dialysis patients: a prospective observational study.

Rognant N, Alamartine E, Aldigier JC, Combe C, Vendrely B, Deteix P, Cluzel P, Juillard L, Vrtovsnik F, Maurice C, Fave S, Laville M.

BMC Nephrol. 2013 Feb 20;14:41. doi: 10.1186/1471-2369-14-41.

44.

Safety of meglumine gadoterate (Gd-DOTA)-enhanced MRI compared to unenhanced MRI in patients with chronic kidney disease (RESCUE study).

Deray G, Rouviere O, Bacigalupo L, Maes B, Hannedouche T, Vrtovsnik F, Rigothier C, Billiouw JM, Campioni P, Ferreiros J, Devos D, Alison D, Glowacki F, Boffa JJ, Marti-Bonmati L.

Eur Radiol. 2013 May;23(5):1250-9. doi: 10.1007/s00330-012-2705-x. Epub 2012 Dec 5.

45.

The IgA1 immune complex-mediated activation of the MAPK/ERK kinase pathway in mesangial cells is associated with glomerular damage in IgA nephropathy.

Tamouza H, Chemouny JM, Raskova Kafkova L, Berthelot L, Flamant M, Demion M, Mesnard L, Paubelle E, Walker F, Julian BA, Tissandié E, Tiwari MK, Camara NO, Vrtovsnik F, Benhamou M, Novak J, Monteiro RC, Moura IC.

Kidney Int. 2012 Dec;82(12):1284-96. doi: 10.1038/ki.2012.192. Epub 2012 Sep 5.

46.

ANCA-associated diseases and lung carcinomas: a five-case series.

Chemouny JM, Pagnoux C, Caudwell V, Karras A, Borie R, Guillevin L, Vrtovsnik F, Daugas E.

Clin Nephrol. 2014 Feb;81(2):132-7. doi: 10.5414/CN107407.

PMID:
22948118
47.

GFR estimation using the Cockcroft-Gault, MDRD study, and CKD-EPI equations in the elderly.

Flamant M, Haymann JP, Vidal-Petiot E, Letavernier E, Clerici C, Boffa JJ, Vrtovsnik F.

Am J Kidney Dis. 2012 Nov;60(5):847-9. doi: 10.1053/j.ajkd.2012.08.001. Epub 2012 Aug 30. No abstract available.

PMID:
22938847
48.

The TRPM4 channel controls monocyte and macrophage, but not neutrophil, function for survival in sepsis.

Serafini N, Dahdah A, Barbet G, Demion M, Attout T, Gautier G, Arcos-Fajardo M, Souchet H, Jouvin MH, Vrtovsnik F, Kinet JP, Benhamou M, Monteiro RC, Launay P.

J Immunol. 2012 Oct 1;189(7):3689-99. Epub 2012 Aug 29.

49.

Timing and determinants of erythropoietin deficiency in chronic kidney disease.

Mercadal L, Metzger M, Casadevall N, Haymann JP, Karras A, Boffa JJ, Flamant M, Vrtovsnik F, Stengel B, Froissart M; NephroTest Study Group.

Clin J Am Soc Nephrol. 2012 Jan;7(1):35-42. doi: 10.2215/CJN.04690511. Epub 2011 Nov 17.

50.

Early steroid withdrawal and optimization of mycophenolic acid exposure in kidney transplant recipients receiving mycophenolate mofetil.

Le Meur Y, Thierry A, Glowacki F, Rerolle JP, Garrigue V, Ouali N, Heng AE, Delahousse M, Albano L, Lang P, Couzi L, Jaureguy M, Lebranchu Y, Mousson C, Glotz D, Kessler M, Vrtovsnik F, Rouanet S, Tagieva N, Kamar N.

Transplantation. 2011 Dec 15;92(11):1244-51. doi: 10.1097/TP.0b013e318234e134.

PMID:
22067312

Supplemental Content

Loading ...
Support Center